WHY MSc Cell and Gene Therapies?
Innovative and groundbreaking topic
Cell and gene therapies (CGTs) are at the forefront of modern advancements in health and they are expected to transform the landscape of biological medications, providing hope to unmet medical needs. CGT therapies are constantly added to the product portfolios of big pharma and biotech businesses, while regulators expect to authorize 10 to 20 CGT products per year by 2025.
Prospects of industrial application
In a field where the number of cell and gene therapy developers has grown by 90% since 2012 and health professionals’ employment needs are growing exponentially, prospects of achieving a career path in leading companies in the field are very high.
Theory and practice
A unique experience to get involved in CGT hands – on activities under real GMP lab conditions. Through the combination of theory and practice, students get engaged in direct application of skills, theories, and procedures related to development of CGT therapies.
Invited Worldwide class speakers
An assembly of experts in the field of CGTs will be presenting the lectures of the course, providing the opportunity to to be taught by those who lead this groundbreaking field and to gain as much knowledge as possible from specialists who have already attained mastery in the fields.
Watch here the video of the Director of the Master Program explaining the importance of Cell and Gene Therapies
Key information
APPLICATION DEADLINE
January 31, 2022
Start date (2022/2023)
February 23, 2022
Duration of the course
2 semesters, 60 ECTS credits
LANGUAGE
English
TIMEPLAN
Worker friendly (evening/ WE classes)
LOCATION
Athens or Patras, web-based courses
TUITION FEES
4.000 € (exemptions and scholarships available)
This course is a bi-institutional programme of postgraduate studies of the School of Medicine of Patras and the Dept. of Biomedical Sciences of the University of West Attica.
ABOUT
Legislation
This is a bi-institutional program of postgraduate studies of the School of Medicine of the University of Patras and the Department of Biomedical Sciences of the University of West Attica. You can find the Government Gazette and the Regulation of Studies here.
Goal
The “MSc Cell and Gene Therapies” aims to provide high-level postgraduate education in the field of Advanced Therapeutic Medicinal Products (ATMPs) and especially of Cell and Gene Therapies (CGT).
Target audience
Students with a bachelor degree in life sciences or equivalent interested in a role in the C and GT field in academic, clinical, industrial and regulatory settings. You may find the entry requirements and the selection process here.
Curriculum
This program covers all aspects of cell and gene therapy with the purpose to train graduate scientists of various expertise in the fields of production, distribution, clinical evaluation and clinical implementation of CGTs and study both the biological substrate of CGTs and the regulatory framework for their production and their application. The course includes also training in basic cell biology, lab techniques and statistics. You may find the modules and the course objectives here.
The Value Proposition
The master program will provide the students with a practical profession with high market demand. The high-level training of health and bio related scientists will empower their skills towards employability as executives in private or public sectors in the areas of Biotechnology and Health and scientists with medical direction will be trained in the fields of CGT clinical research, translation research and their application for treatment of incurable diseases. MSc graduates may proceed to PhD studies.
Teaching Methods
Face to face and on-line lectures and seminars, virtual reality training, individual and group assignments, practical training in GMP Labs of industrial partners (Theracell) or of the Institute of Cell Therapy “Dimitris Lois”, Univeristy of Patras.
Tutors
An international assembly of experts who lead this groundbreaking field of CGTs will be providing lectures and seminars. See the list of lecturers here.
Graduate Degree
MSc in «Cell and Gene Therapies: from bench to bedside and Good Manufacturing Practices» awarded from University of Patras and University of West Attica.
Important dates
- Applications start 29th November 2021.
- Applications End 31st January 2022
- Selection Interview 8th of February 2022
- Selection Announced 15th of February 2022
- Selection of scholarships and students with exemption of fees 15th February 2022
- Submission of documents 16th -19th February 2022
- Deadline for 25% of the tuition fees 19th February 2022
- Start of courses the 23rd of February 2022
